Lumanity (@lumanity) header
Lumanity (@lumanity) profile picture

Our unique & agile approach equip you to thrive in an ever-changing healthcare marketplace by accelerating & optimizing access to life-changing medicines

Joined February 2022
Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)Photo by Lumanity (@lumanity)
Your story is one of the most powerful tools in advocacy. We are proud to sponsor the 2026 #BioNJ #PatientAdvocacy Summit on November 10. Will we see you next week? Join us. buff.ly/9WLjvWO
5
Real-world data can tell us what happened to patients — the diagnoses, the costs, the hospitalizations. But it often can't tell us what it was like. The solution is a multi-method approach: buff.ly/toGMI4u #PatientExperienceData #RealWorldEvidence #PatientReportedData
6
Will you be at the 2026 BIO NJ Patient Advocacy Summit? Our colleagues will be at the event and would love to connect with you! Email [email protected] if you'd like to schedule time to connect. For more information about the summit, visit: buff.ly/Q0JgDWD
5
We are proud supporters of Light the Night by Blood Cancer United, raising money to fund treatments for patients who are dealing with all forms of blood cancers. Join us, get involved, or support #LightTheNight: buff.ly/nBeXMXn #BloodCancerUnited #BloodCancer
16
The evidence you build today could determine the access you earn tomorrow. Our new whitepaper covers JCA readiness, trial representativeness and early patient partnerships, plus five actions to take before the clock starts. Download it here: buff.ly/3iGxk0L
4
Read our whitepaper to discover the benefits of in-trial interviews and why regulators and HTA bodies are increasingly valuing patient experience data in decision making. buff.ly/b5I9xmL #LumanityPerspectives #PCO #PatientVoice #HTA
14
Lumanity is attending SITC 2026 in Phoenix. AZ. We look forward to learning about the latest science, and breakthroughs in cancer immunotherapy. buff.ly/N3Sqr0u
16
Last call: our live conversation with Fierce Pharma is this week. Common Ground: When Patients, Providers and Pharma Build Partnerships That Last Oct 29 | 11:00 AM ET | 60 minutes Seats are filling up! Save yours before we go live. Register here: buff.ly/kevRRbt
8
The EU Health Data Space (in force since March 2025) opens health data for research across Europe. But access isn't the same as evidence quality. PHARMO explains why the real work starts after data access is granted: buff.ly/JrN9aQf
14
There are the five pillars of our Common Ground framework, a methodology for multi-stakeholder engagement that puts patient communities at the center, not the margins. Read the whitepaper: buff.ly/DCpHywy
13
What does it take to transform rare disease? Collaboration. Courage. And community. Our Voices of Rare Disease series is now complete. Watch all four stories: buff.ly/OUHEktr #VoicesOfRareDisease #Lumanity #RareDiseaseAdvocacy
14
5 questions. Run them before you write a brief. Run them again before final approval. Download the Behavioral Barrier Checklist: buff.ly/HXbzN1l
10
We are proud supporters of Light the Night by Blood Cancer United, raising money to fund treatments for patients who are dealing with all forms of blood cancers. Get involved or support Light the Night: buff.ly/sg0dq1K #LightTheNight #BloodCancerUnited #BloodCancer
16
We are proud supporters of Light the Night by Blood Cancer United, raising funds to treat patients with all forms of blood cancers. Get involved or support #LightTheNight. To donate or to join Team Lumanity, visit: buff.ly/cdeP2Lh #BloodCancerUnited #BloodCancer
14
Join Michael Parisi, John Howley, and Jess Berard at the BIONJ C-Suite Summit on October 15. Want to connect while in Bridgewater? Reach out to our staff directly or email [email protected] to find time on-site. For more on the event, visit buff.ly/2o5KQsk
47
MFN pricing is dominating headlines. Is the reaction proportionate? Our new whitepaper breaks down 3 factors limiting its reach: • Most branded revenue likely exempt • Timing rarely aligns with US launch • Skipping ex-US launches backfires Download: buff.ly/ugYMR0U
8
Heading to ISPOR Europe 2026 in Vienna in November? The Lumanity team will be on-site at booth #611, ready to help you navigate evolving policy shifts, shape compelling value stories, and share insights. Find out more on our website: buff.ly/Fl9Zp8X
8
In this live webinar, panelists unpack what it really takes to build partnerships that last, and how to tell the difference between genuine engagement and performative check-the-box efforts. Register for the live conversation: buff.ly/kevRRbt
39
Convinced HCPs still aren't acting? The barrier isn't the data. It's usually confidence, friction, or habit. See the framework: buff.ly/HXbzN1l
9
Four advocates. Four conditions. Four communities transformed by the courage to speak up, push back, and drive change. Watch the full Voices of Rare Disease series: buff.ly/OUHEktr #RareDisease #HealthcareAdvocacy #PatientCommunity
9